Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Accurate Wealth Management LLC

Accurate Wealth Management LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,978 shares of the medical equipment provider’s stock after purchasing an additional 373 shares during the quarter. Accurate Wealth Management LLC’s holdings in Intuitive Surgical were worth $3,273,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in ISRG. Godsey & Gibb Inc. increased its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth $33,000. Mark Sheptoff Financial Planning LLC acquired a new position in Intuitive Surgical in the second quarter valued at $37,000. Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical during the third quarter valued at about $38,000. Finally, DT Investment Partners LLC grew its holdings in shares of Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 108 shares of the stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock worth $25,012,927 over the last ninety days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 0.2 %

Shares of NASDAQ ISRG opened at $538.88 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $355.17 and a 52-week high of $556.23. The stock has a market capitalization of $191.94 billion, a P/E ratio of 86.64, a PEG ratio of 5.31 and a beta of 1.39. The stock’s 50 day moving average price is $537.05 and its two-hundred day moving average price is $496.50.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on ISRG shares. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 11th. Truist Financial upped their target price on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Leerink Partners upped their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.